Task: Answer the multiple choice question.
Question: Which drug exhibits a -27.892% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) Cc1ccc2nc(SCc3cccc([N+](=O)[O-])c3)nc(C)c2c1
b.) C#CCSc1nc(=O)c2cccnc2n1-c1ccc(C)cc1
Answer: b. C#CCSc1nc(=O)c2cccnc2n1-c1ccc(C)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
C#CCSc1nc(=O)c2cccnc2n1-c1ccc(C)cc1
C#CCSc1nc(=O)c2cccnc2n1-c1ccc(C)cc1
2-prop-2-ynylsulfanyl-1-(4-methylphenyl)pyrido[2,3-d]pyrimidin-4-one